Raphael Pharmaceutical (RAPH) Depreciation and Depletion (2023)
Raphael Pharmaceutical's (RAPH) quarterly Depreciation and Depletion came in at $1000.0 in Q1 2023.
Raphael Pharmaceutical (RAPH) Depreciation and Depletion (2023) Analysis & Trends
Raphael Pharmaceutical has disclosed Depreciation and Depletion across 1 years of filings, most recently posting $1000.0 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Raphael Pharmaceutical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |